UNI-MB - logo
UMNIK - logo
 
E-resources
Peer reviewed Open access
  • Junqueira, Caroline; Barbosa, Camila R R; Costa, Pedro A C; Teixeira-Carvalho, Andréa; Castro, Guilherme; Sen Santara, Sumit; Barbosa, Rafael P; Dotiwala, Farokh; Pereira, Dhelio B; Antonelli, Lis R; Lieberman, Judy; Gazzinelli, Ricardo T

    Nature medicine, 09/2018, Volume: 24, Issue: 9
    Journal Article

    Plasmodium vivax causes approximately 100 million clinical malaria cases yearly . The basis of protective immunity is poorly understood and thought to be mediated by antibodies . Cytotoxic CD8 T cells protect against other intracellular parasites by detecting parasite peptides presented by human leukocyte antigen class I on host cells. Cytotoxic CD8 T cells kill parasite-infected mammalian cells and intracellular parasites by releasing their cytotoxic granules . Perforin delivers the antimicrobial peptide granulysin and death-inducing granzymes into the host cell, and granulysin then delivers granzymes into the parasite. Cytotoxic CD8 T cells were thought to have no role against Plasmodium spp. blood stages because red blood cells generally do not express human leukocyte antigen class I . However, P. vivax infects reticulocytes that retain the protein translation machinery. Here we show that P. vivax-infected reticulocytes express human leukocyte antigen class I. Infected patient circulating CD8 T cells highly express cytotoxic proteins and recognize and form immunological synapses with P. vivax-infected reticulocytes in a human leukocyte antigen-dependent manner, releasing their cytotoxic granules to kill both host cell and intracellular parasite, preventing reinvasion. P. vivax-infected reticulocytes and parasite killing is perforin independent, but depends on granulysin, which generally efficiently forms pores only in microbial membranes . We find that P. vivax depletes cholesterol from the P. vivax-infected reticulocyte cell membrane, rendering it granulysin-susceptible. This unexpected T cell defense might be mobilized to improve P. vivax vaccine efficacy.